NAIK, Vaishnavi; DARANDALE, Akshata; PAL, Pooja. Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: “Cardiovascular and Renal Benefits and Risks”. Cardiovascular Disease Prevention and Control, [S. l.], v. 1, n. 1, p. 29–38, 2026. DOI: 10.64229/v3v43h95. Disponível em: https://cdpc.gospub.com/cdpc/article/view/3. Acesso em: 17 apr. 2026.